BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 30482621)

  • 1. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT.
    Ciammaichella A; Ferrigno F; Basta A; D'Amico M; Biancofiore I; Nardi V; Ponzi S; Graziani R; Gennari N; Vittoria Orsale M; Fini I; Paonessa G; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127207. PubMed ID: 32354566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
    Tatipaka HB; Gillespie JR; Chatterjee AK; Norcross NR; Hulverson MA; Ranade RM; Nagendar P; Creason SA; McQueen J; Duster NA; Nagle A; Supek F; Molteni V; Wenzler T; Brun R; Glynne R; Buckner FS; Gelb MH
    J Med Chem; 2014 Feb; 57(3):828-35. PubMed ID: 24354316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
    Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sickness.
    Navarro G; Chokpaiboon S; De Muylder G; Bray WM; Nisam SC; McKerrow JH; Pudhom K; Linington RG
    PLoS One; 2012; 7(9):e46172. PubMed ID: 23029428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
    Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
    J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.
    Rahmani R; Ban K; Jones AJ; Ferrins L; Ganame D; Sykes ML; Avery VM; White KL; Ryan E; Kaiser M; Charman SA; Baell JB
    J Med Chem; 2015 Sep; 58(17):6753-65. PubMed ID: 26247439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
    Veerman J; van den Bergh T; Orrling KM; Jansen C; Cos P; Maes L; Chatelain E; Ioset JR; Edink EE; Tenor H; Seebeck T; de Esch I; Leurs R; Sterk GJ
    Bioorg Med Chem; 2016 Apr; 24(7):1573-81. PubMed ID: 26935942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis.
    Samant BS; Sukhthankar MG
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1015-8. PubMed ID: 21211967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
    Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.
    Ponzi S; Bresciani A; Kaiser M; Nardi V; Nizi E; Ontoria JM; Pace P; Paonessa G; Summa V; Harper S
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127052. PubMed ID: 32113841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American Trypanosomiases.
    Ghashghaei O; Kielland N; Revés M; Taylor MC; Kelly JM; Di Pietro O; Muñoz-Torrero D; Pérez B; Lavilla R
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29337878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.